Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 2/20 | 0.81 |
| ▸ | ITGB3 | P05106 | 2/20 | 0.65 |
| ▸ | ITGA2B | P08514 | 2/20 | 0.65 |
| ▸ | PSMB5 | P28074 | 2/20 | 0.64 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.60 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.60 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.60 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.60 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.60 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.60 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.60 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.60 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.60 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.60 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.60 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.58 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4066786 | 1.00 | FAAH (0.81) | FAAHITGB3ITGA2BPSMB5HDAC3 | |
| SCHEMBL9506671 | 1.00 | FAAH (0.81) | FAAHITGB3ITGA2BPSMB5HDAC3 | |
| SCHEMBL9716823 | 1.00 | FAAH (0.81) | FAAHITGB3ITGA2BPSMB5HDAC3 | |
| SCHEMBL1815009 | 1.00 | FAAH (0.81) | FAAHITGB3ITGA2BPSMB5HDAC3 | |
| SCHEMBL9666114 | 1.00 | FAAH (0.81) | FAAHITGB3ITGA2BPSMB5HDAC3 | |
| SCHEMBL22494096 | 1.00 | FAAH (0.81) | FAAHITGB3ITGA2BPSMB5HDAC3 | |
| SCHEMBL22494095 | 1.00 | FAAH (0.81) | FAAHITGB3ITGA2BPSMB5HDAC3 | |
| SCHEMBL21998924 | 1.00 | FAAH (0.81) | FAAHITGB3ITGA2BPSMB5HDAC3 | |
| SCHEMBL22494097 | 1.00 | FAAH (0.81) | FAAHITGB3ITGA2BPSMB5HDAC3 | |
| SCHEMBL15285319 | 1.00 | FAAH (0.81) | FAAHITGB3ITGA2BPSMB5HDAC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 79 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250000948-A1 | SOLID COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND AN ACYLATED AMINO ACID | ADOCIA (FR) | 2025-01-02 | — | — | US | claimed |
| EP-4433093-A1 | SOLID COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND AN ACYLATED AMINO ACID | Adocia (FR) | 2024-09-25 | — | — | EP | claimed |
| CN-118488855-A | Solid composition comprising peptide or protein and acylated amino acid | 阿道恰公司 | 2024-08-13 | — | — | CN | claimed |
| EP-4299057-A1 | SOLID COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND AN ACYLATED AMINO ACID | Adocia (FR) | 2024-01-03 | — | — | EP | claimed |
| WO-2023084118-A1 | SOLID COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND AN ACYLATED AMINO ACID | ADOCIA (FR) | 2023-05-19 | — | — | WO | claimed |
| EP-4180060-A1 | SOLID COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND AN ACYLATED AMINO ACID | Adocia (FR) | 2023-05-17 | — | — | EP | claimed |
| US-20150086694-A1 | N-Acyl-Amino Acid Derivatives for Improvement of the Flavour Profile Edible Compositions | GIVAUDAN SA (CH) | 2015-03-26 | — | — | US | claimed |
| US-20150072060-A1 | Organic Compounds | GIVAUDAN SA (CH) | 2015-03-12 | — | — | US | claimed |
| US-20150050408-A1 | Powder Flavour Composition | GIVAUDAN SA (CH) | 2015-02-19 | — | — | US | claimed |
| EP-2830438-A2 | N-ACYL-AMINO ACID DERIVATIVES AS FOOD FLAVOURING COMPOUNDS, POWDER COMPOSITIONS CONTAINING THEM | Givaudan SA (CH) | 2015-02-04 | — | — | EP | claimed |
| EP-2830439-A2 | N-ACYL-AMINO ACID DERIVATIVES FOR IMPROVEMENT OF THE FLAVOUR PROFILE EDIBLE COMPOSITIONS | Givaudan SA (CH) | 2015-02-04 | — | — | EP | claimed |
| EP-2830440-A2 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2015-02-04 | — | — | EP | claimed |
| WO-2013148965-A2 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN S.A. (CH) | 2013-10-03 | — | — | WO | claimed |
| WO-2013149031-A2 | POWDER FLAVOUR COMPOSITION | GIVAUDAN S.A. (CH) | 2013-10-03 | — | — | WO | claimed |
| WO-2013149035-A2 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN S.A. (CH) | 2013-10-03 | — | — | WO | claimed |
| EP-0670717-B1 | SUPPORTED LIQUID MEMBRANE DELIVERY DEVICES | PFIZER (US) | 1998-11-25 | — | — | EP | claimed |
| US-5603953-A | HYDROPHILIC MATERIAL SURROUNDED BY MICROPOROUS SUPPORTING WALL HAVING HYDROPHOBIC LIQUID ENTRAINED IN PORES, WITH VARIABLE WATER PERMEABILITY, FOR CONTROLLED DRUG DELIVERY | PFIZER INC. (US) | 1997-02-18 | — | — | US | claimed |
| EP-0670717-A1 | SUPPORTED LIQUID MEMBRANE DELIVERY DEVICES | PFIZER INC. (US) | 1995-09-13 | — | — | EP | claimed |
| WO-1994012159-A1 | SUPPORTED LIQUID MEMBRANE DELIVERY DEVICES | PFIZER INC. (US) | 1994-06-09 | — | — | WO | claimed |
| US-20250387340-A1 | COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND AN ACYLATED AMINO ACID | ADOCIA (FR) | 2025-12-25 | — | — | US | disclosed |
| EP-4662197-A1 | METHOD FOR PURIFICATION OF AMINO ACID SURFACTANTS | BASF SE (DE) | 2025-12-17 | — | — | EP | disclosed |
| EP-4547267-A1 | COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND AN ACYLATED AMINO ACID | Adocia (FR) | 2025-05-07 | — | — | EP | disclosed |
| CN-119486752-A | Compositions comprising peptides or proteins and acylated amino acids | 阿道恰公司 | 2025-02-18 | — | — | CN | disclosed |
| US-20250000948-A1 | SOLID COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND AN ACYLATED AMINO ACID | ADOCIA (FR) | 2025-01-02 | — | — | US | disclosed |
| EP-4433093-A1 | SOLID COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND AN ACYLATED AMINO ACID | Adocia (FR) | 2024-09-25 | — | — | EP | disclosed |
| WO-2024165426-A1 | METHOD FOR PURIFICATION OF AMINO ACID SURFACTANTS | BASF SE (DE) | 2024-08-15 | — | — | WO | disclosed |
| EP-4414360-A1 | METHOD FOR PURIFICATION OF AMINO ACID SURFACTANTS | BASF SE (DE) | 2024-08-14 | — | — | EP | disclosed |
| CN-118488855-A | Solid composition comprising peptide or protein and acylated amino acid | 阿道恰公司 | 2024-08-13 | — | — | CN | disclosed |
| WO-2024003400-A1 | COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND AN ACYLATED AMINO ACID | ADOCIA (FR) | 2024-01-04 | — | — | WO | disclosed |
| EP-4299057-A1 | SOLID COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND AN ACYLATED AMINO ACID | Adocia (FR) | 2024-01-03 | — | — | EP | disclosed |
| EP-4299071-A1 | COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND AN ACYLATED AMINO ACID | Adocia (FR) | 2024-01-03 | — | — | EP | disclosed |
| WO-2023084118-A1 | SOLID COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND AN ACYLATED AMINO ACID | ADOCIA (FR) | 2023-05-19 | — | — | WO | disclosed |
| EP-4180060-A1 | SOLID COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND AN ACYLATED AMINO ACID | Adocia (FR) | 2023-05-17 | — | — | EP | disclosed |
| US-11559071-B2 | N-acyl-amino acid derivatives for improvement of the flavour profile of edible compositions | GIVAUDAN SA (CH) | 2023-01-24 | — | — | US | disclosed |
| US-11524933-B2 | In or relating to organic compounds | GIVAUDAN SA (CH) | 2022-12-13 | — | — | US | disclosed |
| US-11492326-B2 | Organic compounds | GIVAUDAN SA (CH) | 2022-11-08 | — | — | US | disclosed |
| CN-108567129-B | N-acyl-amino acid derivatives for improving flavor profile of edible compositions | 奇华顿股份有限公司 | 2021-10-29 | — | — | CN | disclosed |
| US-10975018-B2 | Organic compounds | GIVAUDAN SA (CH) | 2021-04-13 | — | — | US | disclosed |
| CN-105658086-B | Method for purifying N-acyl amino acids by using propylene glycol as extraction solvent | 奇华顿股份有限公司 | 2021-04-06 | — | — | CN | disclosed |
| US-20210022376-A1 | N-ACYL-AMINO ACID DERIVATIVES FOR IMPROVEMENT OF THE FLAVOUR PROFILE OF EDIBLE COMPOSITIONS | GIVAUDAN SA (CH) | 2021-01-28 | — | — | US | disclosed |
| US-10836712-B2 | Organic compounds | GIVAUDAN S.A. (CH) | 2020-11-17 | — | — | US | disclosed |
| EP-2516473-B1 | ANIONIC POLYSACCHARIDES FUNCTIONALISED WITH A DERIVATIVE OF HYDROPHOBIC ACID | ADOCIA (FR) | 2020-09-30 | — | — | EP | disclosed |
| US-20200299229-A1 | Organic Compounds | GIVAUDAN SA (CH) | 2020-09-24 | — | — | US | disclosed |
| US-20200290952-A1 | In or Relating to Organic Compounds | GIVAUDAN SA (CH) | 2020-09-17 | — | — | US | disclosed |
| US-10582715-B2 | Powder flavour composition | GIVAUDAN SA (CH) | 2020-03-10 | — | — | US | disclosed |
| US-10449256-B2 | Injectable solution at pH 7 comprising at least one basal insulin the isoelectric point of which is between 5.8 and 8.5 and a hydrophobized anionic polymer | ADOCIA (FR) | 2019-10-22 | — | — | US | disclosed |
| CN-104219966-B | N- sulphonyl-amino acid derivative as food fragrance compound | 奇华顿股份有限公司 | 2019-05-28 | — | — | CN | disclosed |
| CN-108567129-A | N- sulphonyl-amino acid derivatives for improving edible composition aromatic property | 奇华顿股份有限公司 | 2018-09-25 | — | — | CN | disclosed |
| CN-104219963-B | As food fragrance compound N- sulphonyl-aminos acid derivative, include their powder composition | 奇华顿股份有限公司 | 2018-08-14 | — | — | CN | disclosed |
| US-20180169249-A1 | INJECTABLE SOLUTION AT PH 7 COMPRISING AT LEAST ONE BASAL INSULIN THE ISOELECTRIC POINT OF WHICH IS BETWEEN 5.8 AND 8.5 AND A HYDROPHOBIZED ANIONIC POLYMER | ADOCIA (FR) | 2018-06-21 | — | — | US | disclosed |
| US-9493583-B2 | Anionic polysaccharides functionalized by a hydrophobic acid derivative | ADOCIA (FR) | 2016-11-15 | — | — | US | disclosed |
| EP-3065563-A1 | PURIFICATION OF N-ACYL AMINO ACIDS BY USING PROPYLENE GLYCOL AS EXTRACTING SOLVENT | Givaudan S.A. (CH) | 2016-09-14 | — | — | EP | disclosed |
| US-20160214928-A1 | Improvements in or Relating to Organic Compounds | GIVAUDAN SA (CH) | 2016-07-28 | — | — | US | disclosed |
| US-20150314003-A2 | INJECTABLE SOLUTION AT PH 7 COMPRISING AT LEAST ONE BASAL INSULIN THE ISOELECTRIC POINT OF WHICH IS BETWEEN 5.8 AND 8.5 AND A HYDROPHOBIZED ANIONIC POLYMER | ADOCIA (FR) | 2015-11-05 | — | — | US | disclosed |
| US-20150250882-A1 | Fatty Acid Acylated Amino Acids for Growth Hormone Delivery | NOVO NORDISK HEALTHCARE AG (CH) | 2015-09-10 | — | — | US | disclosed |
| EP-2908845-A1 | FATTY ACID ACYLATED AMINO ACIDS FOR GROWTH HORMONE DELIVERY | Novo Nordisk Health Care AG (CH) | 2015-08-26 | — | — | EP | disclosed |
| WO-2015049275-A1 | PURIFICATION OF N-ACYL AMINO ACIDS BY USING PROPYLENE GLYCOL AS EXTRACTING SOLVENT | GIVAUDAN SA (CH) | 2015-04-09 | — | — | WO | disclosed |
| US-20150072060-A1 | Organic Compounds | GIVAUDAN SA (CH) | 2015-03-12 | — | — | US | disclosed |
| US-20150050408-A1 | Powder Flavour Composition | GIVAUDAN SA (CH) | 2015-02-19 | — | — | US | disclosed |
| EP-2830439-A2 | N-ACYL-AMINO ACID DERIVATIVES FOR IMPROVEMENT OF THE FLAVOUR PROFILE EDIBLE COMPOSITIONS | Givaudan SA (CH) | 2015-02-04 | — | — | EP | disclosed |
| EP-2830438-A2 | N-ACYL-AMINO ACID DERIVATIVES AS FOOD FLAVOURING COMPOUNDS, POWDER COMPOSITIONS CONTAINING THEM | Givaudan SA (CH) | 2015-02-04 | — | — | EP | disclosed |
| EP-2830440-A2 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2015-02-04 | — | — | EP | disclosed |
| US-20140249079-A1 | INJECTABLE SOLUTION AT PH 7 COMPRISING AT LEAST ONE BASAL INSULIN THE ISOELECTRIC POINT OF WHICH IS BETWEEN 5.8 AND 8.5 AND A HYDROPHOBIZED ANONIC POLYMER | ADOCIA (FR) | 2014-09-04 | — | — | US | disclosed |
| WO-2014060512-A1 | FATTY ACID ACYLATED AMINO ACIDS FOR GROWTH HORMONE DELIVERY | NOVO NORDISK HEALTH CARE AG (CH) | 2014-04-24 | — | — | WO | disclosed |
| WO-2013148965-A2 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN S.A. (CH) | 2013-10-03 | — | — | WO | disclosed |
| WO-2013149035-A2 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN S.A. (CH) | 2013-10-03 | — | — | WO | disclosed |
| WO-2013149031-A2 | POWDER FLAVOUR COMPOSITION | GIVAUDAN S.A. (CH) | 2013-10-03 | — | — | WO | disclosed |
| US-20130245246-A1 | POLYSACCHARIDES COMPRISING CARBOXYL FUNCTIONAL GROUPS SUBSTITUTED BY A HYDROPHOBIC ALCOHOL DERIVATIVE | ADOCIA (FR) | 2013-09-19 | — | — | US | disclosed |
| EP-2516473-A1 | ANIONIC POLYSACCHARIDES FUNCTIONALISED BY A HYDROPHOBIC ACID DERIVATIVE | Adocia (FR) | 2012-10-31 | — | — | EP | disclosed |
| EP-2501389-A1 | POLYSACCHARIDE / BMP COMPLEXES WHICH ARE SOLUBLE AT PHYSIOLOGICAL PH | Adocia (FR) | 2012-09-26 | — | — | EP | disclosed |
| US-20110178011-A1 | Polysaccharide/BMP complexes which are soluble at physiological pH | ADOCIA (FR) | 2011-07-21 | — | — | US | disclosed |
| US-20110172166-A1 | Anionic polysaccharides functionalized by a hydrophobic acid derivative | ADOCIA (FR) | 2011-07-14 | — | — | US | disclosed |
| WO-2011077405-A1 | ANIONIC POLYSACCHARIDES FUNCTIONALISED BY A HYDROPHOBIC ACID DERIVATIVE | ADOCIA (FR) | 2011-06-30 | — | — | WO | disclosed |
| WO-2011061615-A1 | POLYSACCHARIDE / BMP COMPLEXES WHICH ARE SOLUBLE AT PHYSIOLOGICAL PH | ADOCIA (FR) | 2011-05-26 | — | — | WO | disclosed |
| EP-0178911-B1 | COMPOSITION CONTAINING A PENEM OR CARBAPENEM ANTIBIOTIC | SANKYO COMPANY LIMITED (JP) | 1992-01-22 | — | — | EP | disclosed |
| US-4757066-A | Reduces renal toxicity | SANKYO COMPANY LIMITED (JP) | 1988-07-12 | — | — | US | disclosed |
| EP-0178911-A2 | Composition containing a penem or carbapenem antibiotic | SANKYO COMPANY LIMITED (JP) | 1986-04-23 | — | — | EP | disclosed |
| US-4442090-A | ACYLATED AMINO ACID | KYOTO YAKUHIN KOGYO KABUSHIKI KAISHA (JP) | 1984-04-10 | — | — | US | disclosed |
| US-4151198-A | Resolution of N-acyl-DL (+)-phenylalanines | AMERICAN CYANAMID COMPANY (US) | 1979-04-24 | — | — | US | disclosed |
| US-4151198-A | Resolution of N-acyl-DL (+)-phenylalanines | AMERICAN CYANAMID COMPANY (US) | 1979-04-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (18 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110172166-A1 | Anionic polysaccharides functionalized by a hydrophobic acid derivative | ALG1, CD44, FUT6 | FAAH 3193/4885ITGB3 324/4885ITGA2B 453/4885 |
| US-10975018-B2 | Organic compounds | GABRB3, OXGR1, GABRB2 | FAAH 2198/4885ITGB3 627/4885ITGA2B 2183/4885 |
| US-10836712-B2 | Organic compounds | GABRB3, GABRB2, GABRB1 | FAAH 1419/4885ITGB3 765/4885ITGA2B 1889/4885 |
| US-20130245246-A1 | POLYSACCHARIDES COMPRISING CARBOXYL FUNCTIONAL GROUPS SUBSTITUTED BY A HYDROPHOBIC ALCOHOL DERIVATIVE | CD44, B3GAT3, UGCG | FAAH 2153/4885ITGB3 195/4885ITGA2B 414/4885 |
| US-11492326-B2 | Organic compounds | GABRB3, GABRB2, GABRB1 | FAAH 1419/4885ITGB3 765/4885ITGA2B 1889/4885 |
| US-20250000948-A1 | SOLID COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND AN ACYLATED AMINO ACID | NPPA, BCAT1, ANPEP | FAAH 858/4885ITGB3 4058/4885ITGA2B 3499/4885 |
| US-20160214928-A1 | Improvements in or Relating to Organic Compounds | GABRB3, GABRB2, GABRB1 | FAAH 2552/4885ITGB3 446/4885ITGA2B 1820/4885 |
| US-20200299229-A1 | Organic Compounds | GABRB3, GABRB2, GABRB1 | FAAH 1419/4885ITGB3 765/4885ITGA2B 1889/4885 |
| US-20180169249-A1 | INJECTABLE SOLUTION AT PH 7 COMPRISING AT LEAST ONE BASAL INSULIN THE ISOELECTRIC POINT OF WHICH IS BETWEEN 5.8 AND 8.5 AND A HYDROPHOBIZED ANIONIC POLYMER | IAPP, IGFBP5, IDE | FAAH 3264/4885ITGB3 1997/4885ITGA2B 2689/4885 |
| US-20200290952-A1 | In or Relating to Organic Compounds | GABRB3, GABRB1, GABRB2 | FAAH 1197/4885ITGB3 719/4885ITGA2B 2221/4885 |
| US-10449256-B2 | Injectable solution at pH 7 comprising at least one basal insulin the isoelectric point of which is between 5.8 and 8.5 and a hydrophobized anionic polymer | IAPP, IGFBP5, IDE | FAAH 3264/4885ITGB3 1997/4885ITGA2B 2689/4885 |
| US-20150314003-A2 | INJECTABLE SOLUTION AT PH 7 COMPRISING AT LEAST ONE BASAL INSULIN THE ISOELECTRIC POINT OF WHICH IS BETWEEN 5.8 AND 8.5 AND A HYDROPHOBIZED ANIONIC POLYMER | IAPP, IGFBP5, IDE | FAAH 3264/4885ITGB3 1997/4885ITGA2B 2689/4885 |
| US-11524933-B2 | In or relating to organic compounds | GABRB3, GABRB1, GABRB2 | FAAH 1231/4885ITGB3 699/4885ITGA2B 2358/4885 |
| US-20150072060-A1 | Organic Compounds | GABRB3, GABRB2, GABRB1 | FAAH 1419/4885ITGB3 765/4885ITGA2B 1889/4885 |
| US-20250387340-A1 | COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND AN ACYLATED AMINO ACID | NPR1, NPPA, SLC7A1 | FAAH 399/4885ITGB3 2164/4885ITGA2B 2090/4885 |
| US-20150250882-A1 | Fatty Acid Acylated Amino Acids for Growth Hormone Delivery | GHRHR, GHSR, GHITM | FAAH 53/4885ITGB3 4140/4885ITGA2B 3310/4885 |
| US-20140249079-A1 | INJECTABLE SOLUTION AT PH 7 COMPRISING AT LEAST ONE BASAL INSULIN THE ISOELECTRIC POINT OF WHICH IS BETWEEN 5.8 AND 8.5 AND A HYDROPHOBIZED ANONIC POLYMER | IAPP, IGFBP5, IDE | FAAH 2820/4885ITGB3 1514/4885ITGA2B 1938/4885 |
| US-20110178011-A1 | Polysaccharide/BMP complexes which are soluble at physiological pH | BMP1, BMP2, BMP6 | FAAH 4615/4885ITGB3 1719/4885ITGA2B 2161/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.